81 related articles for article (PubMed ID: 1307287)
21. Control of immune complexes by the classical pathway.
Whaley K; Ahmed AE
Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
[TBL] [Abstract][Full Text] [Related]
22. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
[TBL] [Abstract][Full Text] [Related]
23. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
24. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
[TBL] [Abstract][Full Text] [Related]
25. Cellular sites of immunoglobulins. V. An immunological study of the human gall bladder.
Chen S; Tobe T
Digestion; 1974; 10(3):184-90. PubMed ID: 4211858
[No Abstract] [Full Text] [Related]
26. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
27. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
29. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
30. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
31. The role of tissue immune complex, complement activation and its immunopathologic injury in the pathogenesis of the epidemic hemorrhagic fever.
Wang JR; Yang PZ; Wu Q; Sun T; Xu ZY; Dai ZY
Chin Med J (Engl); 1986 Jan; 99(1):21-6. PubMed ID: 2873969
[No Abstract] [Full Text] [Related]
32. Immunoglobulin and complement deposits in the skin and circulating immune complexes in scabies.
Salo OP; Reunala T; Kalimo K; Rantanen T
Acta Derm Venereol; 1982; 62(1):73-6. PubMed ID: 6175145
[TBL] [Abstract][Full Text] [Related]
33. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
34. [Bile duct calculi without calculi in the gallbladder].
Sobański A
Wiad Lek; 1986 Mar; 39(6):369-72. PubMed ID: 3727570
[No Abstract] [Full Text] [Related]
35. Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils.
Amit A; Kindzelskii AL; Zanoni J; Jarvis JN; Petty HR
Cell Immunol; 1999 May; 194(1):47-53. PubMed ID: 10357880
[TBL] [Abstract][Full Text] [Related]
36. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
37. [Echography inthe study of the gallbladder wall].
Maresca G; Mirk P; De Gaetano AM; Colagrande C
Radiol Med; 1982 Apr; 68(4):253-60. PubMed ID: 7111780
[TBL] [Abstract][Full Text] [Related]
38. [Immunologic study of cholelithiasis and chronic biliary inflammation: determination of biliary and serum immunoglobulins and immunoglobulin-secreting cell density in the biliary tract].
Yang Y; Yang KZ; Huang ZQ
Zhonghua Nei Ke Za Zhi; 1985 Sep; 24(9):536-9, 573-4. PubMed ID: 4085306
[No Abstract] [Full Text] [Related]
39. [Disordered immunologic reactivity in patients with chronic calculous cholecystitis].
Koval'chuk LA; Venger IK; Piatnochka VI
Klin Khir (1962); 1989; (9):6-7. PubMed ID: 2593528
[TBL] [Abstract][Full Text] [Related]
40. [The pathogenesis of cardiovascular system lesions in patients with chronic acalculous cholecystitis].
Lykhovskiĭ OI
Lik Sprava; 1998 Dec; (8):99-101. PubMed ID: 10204361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
